YS Biopharma Announces US FDA Clearance Of IND Application for PIKA COVID-19 vaccine
YishengBio recently announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) for PIKA COVID-19 vaccine.
YishengBio Received Approval from Philippines for Phase 2/3 Clinical Trials of PIKA Recombinant COVID-19 vaccine
YishengBio just announced that it received the approval from the Philippines and United Arab Emirates (UAE) to conduct Phase 2/3 clinical trials for its PIKA recombinant COVID-19 vaccine.